Access cutting-edge pulmonary hypertension treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access pulmonary hypertension specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary hypertension treatment provided free
This study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD; Day 1 to Week 12).
Sponsor: Tenax Therapeutics, Inc.
Check if you qualify for this pulmonary hypertension clinical trial in Tucson, AZ
If you're searching for pulmonary hypertension treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.